Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Acetazolamide and CO2 Inhalation on Periodic Breathing During Exercise in Chronic Heart Failure
2007-003836-53Phase 2Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of acetazolamide in chronic heart failure (CHF), sponsored by Centro Cardiologico Monzino. Primary endpoints: Effect of CO2 inhalation on periodic breathing during exercise and Change in number of periodic breathing cycles with chronic acetazolamide treatment. Started Aug 2007; status: completed.
02
Drugs
acetazolamide
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2007-003836-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003836-53.